Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Calidi Biotherapeutics, Inc.

NYSE: CLDI · Life Sciences · 4 alerts · CIK 1855485

Share price
$0.6023Close, Nov 16
Market cap
$2.08M
Shares outstanding
3.45MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Calidi Biotherapeutics, Inc. filings on SEC EDGAR ↗

5:26 PM ET 8-K
Nasdaq/NYSE Compliance Notice

Calidi Biotherapeutics Nasdaq/NYSE Compliance Notice

Calidi Biotherapeutics received a deficiency notice from NYSE American for failing to maintain the minimum stockholders' equity requirement of $4.0 million. The company reported stockholders' equity of $3.1 million as of June 30, 2026, and has until October 21, 2026, to submit a plan to regain compliance by March 21, 2028.

Counterparty
NYSE American LLC
Term
through March 21, 2028
5:01 PM ET 8-K
Capital Raise

Calidi Biotherapeutics Capital Raise of $1.2M

Calidi Biotherapeutics entered into a stock purchase agreement to sell 1,025,640 shares of common stock in a registered direct offering at $1.17 per share. The offering generated gross proceeds of approximately $1.2 million, which the company intends to use for working capital and general corporate purposes.

Value
$1.2M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.